[1]
S. S and P. K, “DRUG REPURPOSING OF COMMERCIALLY AVAILABLE AZOLES AGAINST ASPERGILLOSIS PEROXIREDOXIN ASP F3 ALLERGEN DRUGS”, Innovare J Med Sci, vol. 11, no. 2, pp. 15–19, Mar. 2023.